HOME |
 |
ABOUT US
THERAPEUTIC PROGRAMS
TECHNOLOGY
BUSINESS DEVELOPMENT
INVESTORS
NEWS
CONTACT USWELCOME TO SORRENTO THERAPEUTICS
Sorrento Therapeutics, Inc. is a development-stage biopharmaceutical company focused on applying its proprietary technology platform for the discovery and development of human therapeutic antibodies for the treatment of a variety of disease conditions, including cancer, inflammation, metabolic disease and infectious disease. The Company seeks to construct an antibody library containing fully human antibodies and designed to facilitate the rapid identification and isolation of highly specific, antibody therapeutic product candidates that are fully human and that bind to disease targets a... |
PRESS RELEASE
June 09 , 2010
|
TECHNOLOGY
Sorrento Therapeutics applies a proprietary platform, the STI technology, for the construction of fully human antibody libraries.The STI Technology uses RNA transcription for the amplification of variable immunoglobulin domain sequences. |
 |
TECHNOLOGY ACCESS
|
|
CONTACT US
Sorrento Therapeutics, Inc. AWARD
|
